Companies or hospitals such as Johns Hopkins would request samples or complete reports but she never did.Ĭarreyrou writes about the machinations that drove the company between the years of 20. The health of thousands of patients was put in jeopardy because of bogus readings. Her product would build a disease map for everyone through Theranos’ blood tests and then reverse the illness because doctors could prescribe meds that would stop the progression of the disease.īut the company was in a state of perpetual chaos largely due to Holmes’s irrational unpredictability. Holmes called her company “The Greatest Start-Up in the Valley.”Īn ardent fan of Steve Jobs (her “god”), she labeled her product the “iPod of health care” and was certain it would at some point be in every home in the U.S. (Later this was changed to “a few drops.”) It was an eye-catching phrase. In 2005 her company, Theranos, promised that one drop of blood could be used instead of painful venous blood draws. Holmes dropped out of Stanford at age 19 because she had better things to do: namely, make money.
“Bad Blood” by John Carreyrou, Pulitzer Prize-winning investigative reporter for the Wall Street Journal, is a quintessential story of American greed at its worst. Theranos was the brainchild of Elizabeth Holmes, a young and brilliant biotech scientist with a burning desire to be a billionaire. BAD BLOOD: SECRETS AND LIES IN A SILICON VALLEY STARTUP
0 kommentar(er)
